Ironwood Pharmaceuticals Profit Margin

Ironwood Pharmaceuticals (IRWD) currently reports a profit margin of 69.53% as of June 2026. That compares with 6.64% in the prior-year period — up 946.7% year over year. That is above the Healthcare sector average of 14.34%. Use the charts on this page to explore Ironwood Pharmaceuticals's profit margin history and peer comparisons.

Ironwood Pharmaceuticals's profit margin increased from 6.64% to 69.53% — a 946.7% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Ironwood Pharmaceuticals's profit margin of 69.53% is higher than the Healthcare sector average of 14.34%. That is roughly 384.7% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Ironwood Pharmaceuticals's current 69.53% should be judged against Healthcare norms (sector average: 14.34%) and against IRWD's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 69.53%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 14.34%. From there, open related valuation or income-statement pages for Ironwood Pharmaceuticals, and consider following IRWD for alerts when major investors trade the stock.